bit.bio launches the first commercially available human iPSC-derived disease models for Parkinson’s disease that carry the PRKN R275W mutation.
09.06.2023bit.bio launches the first commercially available human iPSC-derived disease models for Parkinson’s disease that carry the PRKN R275W mutation.